Detalhe da pesquisa
1.
Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection.
Anaerobe
; 41: 58-67, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27262694